Aekffyt中華醫(yī)學(xué)會(huì)系列雜志論文投送介紹信及授權(quán)書 投送期刊

1、最新Aekffyt中華醫(yī)學(xué)會(huì)系列雜志論文投送介紹信及授權(quán)書 投送期刊生命是永恒不斷的創(chuàng)造，因?yàn)樵谒鼉?nèi)部蘊(yùn)含著過剩的精力，它不斷流溢，越出時(shí)間和空間的界限，它不停地追求，以形形色色的自我表現(xiàn)的形式表現(xiàn)出來。泰戈?duì)?中華醫(yī)學(xué)會(huì)系列雜志論文投送介紹信及授權(quán)書 投送期刊： 雜志 稿件編號(hào)： 論文題目： 正式發(fā)表題目編輯部填寫： 主要內(nèi)容及特殊要求： 基金工程請?zhí)峁徟?fù)印件： 單位審查意見：經(jīng)核查，該論文不存在資料不真實(shí)、剽竊他人學(xué)術(shù)成果、一稿多投等學(xué)術(shù)不端行為以及其他與國家有關(guān)法律法規(guī)相違背的問題，同意向貴刊投稿。 負(fù)責(zé)人簽名： 單位蓋章 年 月 日 論文授權(quán)：如該論文被刊用，根據(jù)?中華人民共和國

2、著作權(quán)法?及其實(shí)施條例的有關(guān)規(guī)定，考慮到中華醫(yī)學(xué)會(huì)在該論文正式刊登前所付出的創(chuàng)造性勞動(dòng)，作者同意自該論文正式發(fā)表之日起，將其著作權(quán)及相關(guān)財(cái)產(chǎn)權(quán)轉(zhuǎn)讓給中華醫(yī)學(xué)會(huì)。中華醫(yī)學(xué)會(huì)對該論文的局部或全文具有但不限于以下專有使用權(quán)：匯編權(quán)、發(fā)行權(quán)、復(fù)制權(quán)、翻譯權(quán)、網(wǎng)絡(luò)出版及在全世界范圍的信息傳播權(quán)；許可國內(nèi)外文獻(xiàn)檢索系統(tǒng)和數(shù)據(jù)庫收錄并使用；允許以現(xiàn)有及未來出現(xiàn)的各種介質(zhì)、媒體以及其他語言文字出版和使用；以不違反中華人民共和國現(xiàn)行和以后出臺(tái)的法律規(guī)定的方式使用。該論文發(fā)表后，中華醫(yī)學(xué)會(huì)向作者一次性酌致稿酬，該稿酬已含該論文著作權(quán)轉(zhuǎn)讓的費(fèi)用。 論文作者承諾：1論文系作者請?jiān)诜娇蛑袆澒矗涸瓌?chuàng)性作品，翻譯作品，文獻(xiàn)

3、綜述作品；無知識(shí)產(chǎn)權(quán)糾紛，未一稿多投，不涉及任何形式之保密義務(wù)，未曾以所投期刊使用的語種公開發(fā)表。2未經(jīng)中華醫(yī)學(xué)會(huì)書面許可，不再以發(fā)表該論文期刊使用的語種、任何方式在全世界范圍發(fā)表此文或允許第三方使用該論文。 中華醫(yī)學(xué)會(huì)同意，從該論文發(fā)表之日起，作者享有其非專有使用權(quán)，行使該項(xiàng)權(quán)利時(shí)應(yīng)得到中華醫(yī)學(xué)會(huì)的許可，但不得使用發(fā)表該論文期刊的版式。 中華醫(yī)學(xué)會(huì)和作者任何一方違反上述約定，按照?中華人民共和國著作權(quán)法?的有關(guān)規(guī)定，承當(dāng)相應(yīng)責(zé)任。關(guān)于作者其他權(quán)利的約定，可由作者提出，雙方協(xié)商確定。本授權(quán)書自論文發(fā)表之日起生效，有效期同該論文著作權(quán)的保護(hù)期。 假設(shè)該論文為職務(wù)作品，請作者予以說明，并由作者所在

4、單位與作者共同簽署本授權(quán)書。 論文全部作者親筆簽名請按作者排名順序填寫，姓名后附簽名日期： 1 2 3 4 5 6 7 8 9 10 11 12 通信 辦公 ： ： 地址： ： Email： Covering letter and copyright transfer form for manuscripts submitted to Chinese Medical Association Journals Title of journal： Manuscript No.： Title of manuscript： Title of published articlefilled in by

5、editorial staff： Main content and specific requirements： Funding (copies of grant proposal approval necessary： Institutional approval or comments：This article has been approved to publish in the indicated journal for its originality and integrity without fraud such as fabrication, plagiarism, duplic

6、ate submission, or other issues running against the existing laws or regulations of the Peoples Republic of China. Signature of guarantor: Official Seal: Date: Authorization for the article： In consideration of the Copyright Law of the Peoples Republic of China and relevant regulations and the creat

7、ive contribution to the submitted material made by editors from the Chinese Medical Association (CMA) journals before publication, the author or authors agree to transfer their copyrights or relevant property rights to the CMA on the date of signing this transfer agreement if the article has been ac

8、cepted for publication by CMA journals. The CMA has the rights for, but not limited to compilation, publication, reproduction, interpretation, E-publication, and worldwide transmission of the article in whole or in part, while permitting to be included in, searched and used by retrieval systems such

9、 as Internet or databases in China and abroad, or to be published and used in other languages via different media existing or arising later in the way that is not against the existing law of the Peoples Republic of China or the law issued afterwards. The CMA will make a full payment including copyri

10、ght transfer fee to the author or authors after the article is published. The author or authors confirm that: (1) this writing is an original work (mark with a tick in the pane) ; a translation ; a review article . The article is free from intellectual property dispute, not a duplicate submission no

11、r confidential in any form; it has not been published in the language which CMA journals use. (2) The author or authors will not publish the article worldwide in any form or any media in the language which CMA journals use or permit a third party to use it without the permission from the CMA. The CM

12、A agrees that the author or authors have non-exclusive rights to use the article, but they have to get permission from the CMA before their exercise. However, using the format of CMA journals by which this article is published is forbidden. The CMA or the author or authors should bear the correspond

13、ing responsibilities if either of them infringes this agreement in accordance to the Copyright Law of the Peoples Republic of China. For the other rights of the author or authors, they should be put forward by the author or authors and negotiated by the two sides. This authorization takes effect from the date of the articles publication, and the period of validity should be as long as the copyright protection period of this article. If the article is a work creation, please make a note and sign the agreement by the institut